CHAD DUFORD: Open Payments
NPI 1124461926 · DRAPER, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 14 payments from 9 companies in 2025. Trend: 2023 $572 · 2024 $423 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $98 |
| Edwards Lifesciences Corporation | 1 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Medtronic, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Organon LLC | 1 | $12 |
| Corium, LLC | 1 | $5 |
Products named: VRAYLAR, SAPIEN 3 Ultra RESILIA, JARDIANCE, GARDASIL 9, VENASEAL, AIRSUPRA, MOUNJARO, NEXPLANON.
Industry payments across UT — which companies pay providers there.
